The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Implementation and dissemination of a shared mental model of palliative oncology.
 
Sarah F. D'Ambruoso
Stock and Other Ownership Interests - Bristol-Myers Squibb; Merck; Pfizer
 
John A. Glaspy
No Relationships to Disclose
 
Neil Wenger
No Relationships to Disclose
 
Christopher Pietras
No Relationships to Disclose
 
Kauser Ahmed
No Relationships to Disclose
 
Sara A. Hurvitz
Research Funding - Ambryx (Inst); Amgen (Inst); Bayer (Inst); Biomarin (Inst); Cascadian Therapeutics (Inst); Daiichi Sankyo (Inst); Dignitana (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Immunomedics (Inst); Lilly (Inst); Macrogenics (Inst); Merrimack (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Pieris Pharmaceuticals (Inst); Puma Biotechnology (Inst); Radius Health (Inst); sanofi (Inst); Seagen (Inst)
 
Alexandra Drakaki
Employment - Kyn therapeutics (I)
Leadership - Kyn therapeutics (I)
Stock and Other Ownership Interests - Alimera Sciences (I); Kyn therapeutics (I); Urogen pharma (I)
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Kyn therapeutics; RADMETRIX
Research Funding - Kite/Gilead
Patents, Royalties, Other Intellectual Property - My significant other has 5 patents with UCLA. (I)
Travel, Accommodations, Expenses - AstraZeneca; Lilly
 
Jonathan Wade Goldman
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech/Roche; Lilly; Trovagene; Vortex Biosciences
Speakers' Bureau - Merck
Research Funding - Abbvie; Array BioPharma; Astellas Pharma; Astex Pharmaceuticals; AstraZeneca/MedImmune; Bristol-Myers Squibb; Celgene; Clovis Oncology; Corvus Pharmaceuticals; Genentech/Roche; Lilly; Spectrum Pharmaceuticals; Threshold Pharmaceuticals
 
Sidharth Anand
No Relationships to Disclose
 
Wendy Simon
No Relationships to Disclose
 
Jennie Kung
No Relationships to Disclose
 
Anne Coscarelli
No Relationships to Disclose
 
Lee S. Rosen
Research Funding - Bayer (Inst); Lilly (Inst); Pfizer (Inst); PsiOxus Therapeutics (Inst); Regeneron (Inst)
 
Parvin F. Peddi
No Relationships to Disclose
 
Deborah Wong
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Roche
Research Funding - ARMO BioSciences; AstraZeneca/MedImmune; BioMed Valley Discoveries; Bristol-Myers Squibb; Genentech/Roche; Kura Oncology; Merck Serono; Merck Sharp & Dohme; Regeneron
 
Peter Phung
No Relationships to Disclose
 
Daniel Karlin
No Relationships to Disclose
 
Anne M. Walling
Patents, Royalties, Other Intellectual Property - UpToDate
Other Relationship - AAHPM